Allergies
Conditions
Brief summary
The area of the wheal (mm2) that occurs at the cutaneous level after the administration of the extracts in the prick test for the calculation of the primary endpoint., Estimation of the dose/response relationship in each patient; regression analysis of area values versus concentration in PNU/ml., Determination of the theoretical concentration of extract that produces a papule equivalent to that produced by a solution of histamine at 10 mg/ml
Detailed description
Evaluation of the sensitivity and specificity of the extract concentration defined in the main objective of the study., Safety assessment through descriptive analysis of adverse reactions that could occur during the course of the study
Interventions
Sponsors
Advanced Outcomes Research S.L., Asac Pharmaceutical Inmunology S.A.
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The area of the wheal (mm2) that occurs at the cutaneous level after the administration of the extracts in the prick test for the calculation of the primary endpoint., Estimation of the dose/response relationship in each patient; regression analysis of area values versus concentration in PNU/ml., Determination of the theoretical concentration of extract that produces a papule equivalent to that produced by a solution of histamine at 10 mg/ml | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of the sensitivity and specificity of the extract concentration defined in the main objective of the study., Safety assessment through descriptive analysis of adverse reactions that could occur during the course of the study | — |
Countries
Spain
Outcome results
None listed